PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk

Acta Neuropathol. 2015 Nov;130(5):731-50. doi: 10.1007/s00401-015-1479-z. Epub 2015 Sep 18.

Abstract

Impairment of brain endothelial barrier integrity is critical for cerebral cavernous malformation (CCM) lesion development. The current study investigates changes in tight junction (TJ) complex organization when PDCD10 (CCM3) is mutated/depleted in human brain endothelial cells. Analysis of lesions with CCM3 mutation and brain endothelial cells transfected with CCM3 siRNA (CCM3-knockdown) showed little or no increase in TJ transmembrane and scaffolding proteins mRNA expression, but proteins levels were generally decreased. CCM3-knockdown cells had a redistribution of claudin-5 and occludin from the membrane to the cytosol with no alterations in protein turnover but with diminished protein-protein interactions with ZO-1 and ZO-1 interaction with the actin cytoskeleton. The most profound effect of CCM3 mutation/depletion was on an actin-binding protein, cortactin. CCM3 depletion caused cortactin Ser-phosphorylation, dissociation from ZO-1 and actin, redistribution to the cytosol and degradation. This affected cortical actin ring organization, TJ complex stability and consequently barrier integrity, with constant hyperpermeability to inulin. A potential link between CCM3 depletion and altered cortactin was tonic activation of MAP kinase ERK1/2. ERK1/2 inhibition increased cortactin expression and incorporation into the TJ complex and improved barrier integrity. This study highlights the potential role of CCM3 in regulating TJ complex organization and brain endothelial barrier permeability.

Keywords: Brain endothelial barrier; CCM3; Cortactin; Permeability; Tight junction.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Actins / metabolism
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism*
  • Blood-Brain Barrier / metabolism*
  • Blood-Brain Barrier / pathology
  • Capillary Permeability / physiology*
  • Cells, Cultured
  • Cortactin / metabolism*
  • Cytosol / metabolism
  • Cytosol / pathology
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Humans
  • Intellectual Disability / metabolism*
  • Intellectual Disability / pathology
  • MAP Kinase Signaling System / physiology*
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Micrognathism / metabolism*
  • Micrognathism / pathology
  • Proteasome Endopeptidase Complex / metabolism
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • RNA, Messenger / metabolism
  • Ribs / abnormalities*
  • Ribs / metabolism
  • Ribs / pathology
  • Tight Junctions / metabolism
  • Tight Junctions / pathology
  • Zonula Occludens-1 Protein / metabolism

Substances

  • Actins
  • Apoptosis Regulatory Proteins
  • CTTN protein, human
  • Cortactin
  • Membrane Proteins
  • PDCD10 protein, human
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • TJP1 protein, human
  • Zonula Occludens-1 Protein
  • Proteasome Endopeptidase Complex

Supplementary concepts

  • Cerebral Cavernous Malformations 3